Analyst
Citi
Equibles does not estimate personal net worth.
Yamaguchi is recorded as Analyst at Citi. Yamaguchi has spoken on 2 earnings calls across 1 company, most recently for Takeda Pharmaceutical Co Ltd on October 29, 2026. The companies whose calls Yamaguchi spoke on are classified in the Healthcare sector.
“So thank you very much for taking my question. I have two questions. The first question is regarding Mimurayo. The product looks pretty good, but you hinted that it takes some time to get the reimbursement treatment.”
“The first question is the kind of same question that Maraoka-san asked regarding Horizon 1 and 2. I wasn't quite sure what year you are referring to, Horizon 1 and 2.”
Citi
Analyst
Transcript header (unverified)
Drug Manufacturers - Specialty & Generic · Healthcare
